Quick Answer
MANGOCEUTICALS, INC. reported Operating Income of -$7.97 million for fiscal year 2024.
MANGOCEUTICALS, INC. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2024 | -$7.97M | +13.5% |
| 2023 | -$9.22M | -362.9% |
| 2022 | -$1.99M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$7.54M | -329.0% | -43.2% |
| June 30, 2025 | -$5.27M | -142.9% | -8.6% |
| March 31, 2025 | -$4.85M | -105.0% | -176.1% |
| September 30, 2024 | -$1.76M | +2.3% | +18.9% |
| June 30, 2024 | -$2.17M | +5.4% | +8.4% |
| March 31, 2024 | -$2.37M | +7.5% | -31.6% |
| September 30, 2023 | -$1.80M | -81.4% | +21.5% |
| June 30, 2023 | -$2.29M | -599.1% | +10.4% |
- MANGOCEUTICALS, INC. showed an increase of +13.5% in Operating Income compared to the prior fiscal year.
- Over the 2022–2024 period, MANGOCEUTICALS, INC.’s operating income has declined by 300.3% (from -$1.99 million to -$7.97 million).
- The most recent figure is from MANGOCEUTICALS, INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 20, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: